Article
Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
Journal of neuro-oncology - 1 Jan 2022
Teske Nico, Karschnia Philipp, Weller Jonathan, Siller Sebastian, Dorostkar Mario M, Herms Jochen, von Baumgarten Louisa, Tonn Joerg Christian, Thon Niklas
Abstract excerpt
INTRODUCTION: The cIMPACT-NOW update 6 first introduced glioblastoma diagnosis based on the combination of IDH-wildtype (IDHwt) status and TERT promotor mutation (pTERTmut). In glioblastoma as defined by histopathology according to the WHO 2016 classification, MGMT promotor status is associated with outcome. Whether this is also true in glioblastoma defined by molecular markers is yet unclear. METHODS: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
